M L Brines

Summary

Publications

  1. ncbi Parathyroid hormone-related protein markedly potentiates depolarization-induced catecholamine release in PC12 cells via L-type voltage-sensitive Ca2+ channels
    M L Brines
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Endocrinology 140:646-51. 1999
  2. pmc Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    M L Brines
    The Kenneth S Warren Laboratories, 765 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Proc Natl Acad Sci U S A 97:10526-31. 2000
  3. ncbi Effects of epoetin alfa on the central nervous system
    A Cerami
    Kenneth S. Warren Laboratories, Tarrytown, NY, USA
    Semin Oncol 28:66-70. 2001
  4. ncbi Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy
    N C de Lanerolle
    Section of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520 8039, USA
    Brain Res 686:182-93. 1995

Collaborators

  • P Ghezzi
  • A Cerami
  • C J Cerami
  • N C de Lanerolle
  • D D Spencer
  • S Sundaresan
  • M Gunel
  • M Y Shen

Detail Information

Publications4

  1. ncbi Parathyroid hormone-related protein markedly potentiates depolarization-induced catecholamine release in PC12 cells via L-type voltage-sensitive Ca2+ channels
    M L Brines
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Endocrinology 140:646-51. 1999
    ..In the normal adrenal medulla that expresses both PTHrP and its receptor, PTHrP may act in an autocrine/paracrine fashion to modify catecholamine secretion...
  2. pmc Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    M L Brines
    The Kenneth S Warren Laboratories, 765 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Proc Natl Acad Sci U S A 97:10526-31. 2000
    ..Given r-Hu-EPO's excellent safety profile, clinical trials evaluating systemically administered r-Hu-EPO as a general neuroprotective treatment are warranted...
  3. ncbi Effects of epoetin alfa on the central nervous system
    A Cerami
    Kenneth S. Warren Laboratories, Tarrytown, NY, USA
    Semin Oncol 28:66-70. 2001
    ..These findings suggest future potential therapeutic uses for epoetin alfa beyond its current use to increase erythropoiesis...
  4. ncbi Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy
    N C de Lanerolle
    Section of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520 8039, USA
    Brain Res 686:182-93. 1995
    ....